NO20054216D0 - Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag - Google Patents

Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag

Info

Publication number: NO20054216D0
Authority: NO; Norway
Prior art keywords: dipyridamole; angiotensin; antagonist; combination; acetylsalicylic acid
Prior art date: 2003-02-13

Application number

NO20054216A

Other languages

English (en)

Other versions

NO20054216L (no

Inventor

Axel Riedel

Lutz Hilbrich

James C Gilbert

Michael Humphreys

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-13

Filing date

2005-09-12

Publication date

2005-09-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32870338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054216(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-09-12 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2005-09-12 Publication of NO20054216L publication Critical patent/NO20054216L/no

2005-09-12 Publication of NO20054216D0 publication Critical patent/NO20054216D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20054216A 2003-02-13 2005-09-12 Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag NO20054216D0 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10306179A DE10306179A1 (de)	2003-02-13	2003-02-13	Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
EP03018212		2003-08-08
PCT/EP2004/001208 WO2004071385A2 (en)	2003-02-13	2004-02-10	Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention

Publications (2)

Publication Number	Publication Date
NO20054216L NO20054216L (no)	2005-09-12
NO20054216D0 true NO20054216D0 (no)	2005-09-12

Family

ID=32870338

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054216A NO20054216D0 (no)	2003-02-13	2005-09-12	Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag

Country Status (29)

Country	Link
US (5)	US20040214802A1 (no)
EP (2)	EP1603573B8 (no)
JP (1)	JP2006517557A (no)
KR (1)	KR20050100676A (no)
CN (1)	CN1750830A (no)
AR (1)	AR043173A1 (no)
AT (1)	ATE395921T1 (no)
AU (1)	AU2004212305A1 (no)
BR (1)	BRPI0407457A (no)
CA (1)	CA2515941A1 (no)
DE (2)	DE10306179A1 (no)
DK (1)	DK1603573T3 (no)
EA (1)	EA200501231A1 (no)
EC (1)	ECSP055963A (no)
ES (1)	ES2308147T3 (no)
HR (1)	HRP20050713A2 (no)
MX (1)	MXPA05008572A (no)
NO (1)	NO20054216D0 (no)
NZ (1)	NZ542302A (no)
PE (1)	PE20050191A1 (no)
PL (1)	PL378204A1 (no)
PT (1)	PT1603573E (no)
RS (1)	RS20050618A (no)
SI (1)	SI1603573T1 (no)
TW (1)	TW200501957A (no)
UA (1)	UA83481C2 (no)
UY (1)	UY28182A1 (no)
WO (1)	WO2004071385A2 (no)
ZA (1)	ZA200505956B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10335027A1 (de) *	2003-07-31	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Angiotensin II Rezeptor Antagonisten
DE10306179A1 (de) *	2003-02-13	2004-08-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
CA2437709A1 (en) *	2003-08-08	2005-02-20	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of dipyridamole, acetylsalicylic acid and an angiotensin ii antagonist for treatment and prevention of vascular events
JP2005060359A (ja) *	2003-08-13	2005-03-10	Boehringer Ingelheim Pharma Gmbh & Co Kg	血管系病態の治療及び予防のためのジピリダモール、アセチルサリチル酸及びアンギオテンシンｉｉ拮抗薬の使用
WO2009080301A1 (en) *	2007-12-21	2009-07-02	Boehringer Ingelheim International Gmbh	Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke
US20100069326A1 (en) *	2008-02-14	2010-03-18	Wasimul Haque	Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
WO2009100534A1 (en) *	2008-02-14	2009-08-20	Kardiatech, Inc.	Combination therapy to treat vascular disorders
WO2010097501A2 (en) *	2009-02-26	2010-09-02	Orion Corporation	A combination treatment
US8633158B1 (en) *	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
EP3250201A4 (en) *	2015-01-28	2018-08-01	Realinn Life Science Limited	Compounds for enhancing ppar expression and nuclear translocation and therapeutic use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3031458A (en) *	1958-02-05	1962-04-24	Ciba Pharm Prod Inc	Isoindolines
US3031450A (en)	1959-04-30	1962-04-24	Thomae Gmbh Dr K	Substituted pyrimido-[5, 4-d]-pyrimidines
US3317279A (en) *	1963-03-15	1967-05-02	Pennsalt Chemicals Corp	Polymorph of calcium disilicide and its method of preparation
JPS5671074A (en) *	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3000979A1 (de)	1980-01-12	1981-07-23	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4318477A (en) *	1980-09-22	1982-03-09	Kerpe Stase Z	Pharmaceutical package
DE3124090A1 (de)	1981-06-19	1983-01-05	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue orale dipyridamolformen
CA1334092C (en)	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
DE3627423A1 (de)	1986-08-13	1988-02-18	Thomae Gmbh Dr K	Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
CA1338238C (en)	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5015651A (en)	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) *	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
SI9210098B (sl)	1991-02-06	2000-06-30	Dr. Karl Thomae	Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
EP1013273A1 (en)	1998-12-23	2000-06-28	Novartis AG	Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
SE9903028D0 (sv) *	1999-08-27	1999-08-27	Astra Ab	New use
EP1093814A1 (en) *	1999-10-22	2001-04-25	Boehringer Ingelheim Pharma KG	Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
JP2002138054A (ja) *	2000-08-25	2002-05-14	Takeda Chem Ind Ltd	フィブリノーゲン低下剤
JP2002293742A (ja) *	2001-01-29	2002-10-09	Takeda Chem Ind Ltd	鎮痛・抗炎症剤
JP2003212758A (ja) *	2001-03-16	2003-07-30	Takeda Chem Ind Ltd	徐放性製剤の製造法
DE10306179A1 (de) *	2003-02-13	2004-08-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe

2003
- 2003-02-13 DE DE10306179A patent/DE10306179A1/de not_active Withdrawn
2004
- 2004-02-03 US US10/770,971 patent/US20040214802A1/en not_active Abandoned
- 2004-02-10 AU AU2004212305A patent/AU2004212305A1/en not_active Abandoned
- 2004-02-10 EA EA200501231A patent/EA200501231A1/ru unknown
- 2004-02-10 HR HR20050713A patent/HRP20050713A2/xx not_active Application Discontinuation
- 2004-02-10 WO PCT/EP2004/001208 patent/WO2004071385A2/en not_active Ceased
- 2004-02-10 AT AT04709596T patent/ATE395921T1/de not_active IP Right Cessation
- 2004-02-10 BR BR0407457-2A patent/BRPI0407457A/pt not_active IP Right Cessation
- 2004-02-10 DE DE602004013937T patent/DE602004013937D1/de not_active Expired - Fee Related
- 2004-02-10 ES ES04709596T patent/ES2308147T3/es not_active Expired - Lifetime
- 2004-02-10 UY UY28182A patent/UY28182A1/es not_active Application Discontinuation
- 2004-02-10 JP JP2006501788A patent/JP2006517557A/ja active Pending
- 2004-02-10 SI SI200430789T patent/SI1603573T1/sl unknown
- 2004-02-10 EP EP04709596A patent/EP1603573B8/en not_active Expired - Lifetime
- 2004-02-10 EP EP06121998A patent/EP1733729A1/en not_active Withdrawn
- 2004-02-10 PL PL378204A patent/PL378204A1/pl not_active Application Discontinuation
- 2004-02-10 MX MXPA05008572A patent/MXPA05008572A/es active IP Right Grant
- 2004-02-10 CA CA002515941A patent/CA2515941A1/en not_active Abandoned
- 2004-02-10 RS YUP-2005/0618A patent/RS20050618A/sr unknown
- 2004-02-10 PT PT04709596T patent/PT1603573E/pt unknown
- 2004-02-10 KR KR1020057014826A patent/KR20050100676A/ko not_active Withdrawn
- 2004-02-10 NZ NZ542302A patent/NZ542302A/en unknown
- 2004-02-10 CN CNA2004800041078A patent/CN1750830A/zh active Pending
- 2004-02-10 US US10/544,239 patent/US20070004687A1/en not_active Abandoned
- 2004-02-10 DK DK04709596T patent/DK1603573T3/da active
- 2004-02-11 PE PE2004000151A patent/PE20050191A1/es not_active Application Discontinuation
- 2004-02-12 TW TW093103344A patent/TW200501957A/zh unknown
- 2004-02-13 AR ARP040100446A patent/AR043173A1/es unknown
- 2004-10-02 UA UAA200508697A patent/UA83481C2/uk unknown
2005
- 2005-08-11 EC EC2005005963A patent/ECSP055963A/es unknown
- 2005-09-12 NO NO20054216A patent/NO20054216D0/no not_active Application Discontinuation
2006
- 2006-02-09 ZA ZA200505956A patent/ZA200505956B/en unknown
- 2006-06-29 US US11/478,184 patent/US20060241089A1/en not_active Abandoned
2007
- 2007-12-18 US US11/958,499 patent/US20080113949A1/en not_active Abandoned
2008
- 2008-01-15 US US12/014,181 patent/US20080188497A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2515941A1 (en)	2004-08-26
AR043173A1 (es)	2005-07-20
EP1603573B8 (en)	2009-04-01
CN1750830A (zh)	2006-03-22
DK1603573T3 (da)	2008-09-15
BRPI0407457A (pt)	2006-01-31
ZA200505956B (en)	2006-03-29
TW200501957A (en)	2005-01-16
US20080113949A1 (en)	2008-05-15
PL378204A1 (pl)	2006-03-20
PT1603573E (pt)	2008-06-26
EP1603573B1 (en)	2008-05-21
ES2308147T3 (es)	2008-12-01
ECSP055963A (es)	2006-01-16
EP1603573A2 (en)	2005-12-14
EP1733729A1 (en)	2006-12-20
UA83481C2 (uk)	2008-07-25
US20080188497A1 (en)	2008-08-07
WO2004071385A2 (en)	2004-08-26
NZ542302A (en)	2008-12-24
AU2004212305A1 (en)	2004-08-26
NO20054216L (no)	2005-09-12
WO2004071385A3 (en)	2005-01-06
PE20050191A1 (es)	2005-04-12
MXPA05008572A (es)	2005-11-04
RS20050618A (sr)	2007-09-21
JP2006517557A (ja)	2006-07-27
US20070004687A1 (en)	2007-01-04
SI1603573T1 (sl)	2008-10-31
DE10306179A1 (de)	2004-08-26
KR20050100676A (ko)	2005-10-19
UY28182A1 (es)	2004-09-30
EA200501231A1 (ru)	2006-02-24
US20060241089A1 (en)	2006-10-26
ATE395921T1 (de)	2008-06-15
US20040214802A1 (en)	2004-10-28
HRP20050713A2 (en)	2006-09-30
DE602004013937D1 (de)	2008-07-03

Publication	Publication Date	Title
IS7700A (is)	2005-02-17	Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar
EP1586332A4 (en)	2009-11-11	COMBINED USE OF CARNOSINAS INHIBITOR WITH L-CARNOSINES AND COMPOSITION
EP1490373A4 (en)	2009-11-11	Inhibitors of nucleoside phosphorylases and nucleosideases
LTPA2017004I1 (lt)	2017-03-10	Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
NO20054369D0 (no)	2005-09-21	Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
CY2014001I1 (el)	2014-07-02	Συνδυασμος αζελαστινης και φλουτικαζονης
EP1653970A4 (en)	2008-10-15	GSK-3 HEMMER AND ITS USES
IS7678A (is)	2005-01-28	Samsetning IBAT tálma og málmsalts til að meðhöndla niðurgang
DE60308387D1 (de)	2006-10-26	Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
HRP20160880T1 (hr)	2016-09-23	Formulacija obložene tablete i postupak
IL187353A0 (en)	2008-04-13	Heterocyclic inhibitors of mek and methods of use thereof
ATE423121T1 (de)	2009-03-15	Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DK1592686T3 (da)	2009-10-19	Gyrase-inhibitorer og anvendelser deraf
EP1722797A4 (en)	2008-03-19	ISOCHINOLINE DERIVATIVES AND METHOD FOR THE APPLICATION THEREOF
ZA200804907B (en)	2009-04-29	Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
PL371252A1 (en)	2005-06-13	Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
IS8760A (is)	2008-09-04	Lyfjablanda úr pde4 eða pde3/4 tálma og histamínviðtakamótlyfi
NO20054216D0 (no)	2005-09-12	Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag
EP1812012A4 (en)	2010-02-17	PROTEIN TYROSINE PHOSPHATASE INHIBITOR AND METHOD FOR THEIR USE
IS6966A (is)	2003-09-24	Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
AU2003264261A8 (en)	2004-04-30	Isoprostanes as markers of psychological stress in humans
IL177709A0 (en)	2006-12-31	Caspase inhibitors and uses thereof
EP1688126A4 (en)	2009-11-04	PARAKERATOSIS HEMMER AND TOPICAL COMPOSITION FOR THE SKIN
PL377427A1 (pl)	2006-02-06	Sposoby i kompozycje do leczenia infekcji wirusem opryszczki z zastosowaniem inhibitorów selektywnych względem cyklooksygenazy-2 lub inhibitorów cyklooksygenazy-2 w połączeniu ze środkami przeciwwirusowymi
DK1882054T3 (da)	2019-06-11	Korrosionsbeskyttelsesanordning og fremgangsmåde

Legal Events

Date	Code	Title	Description
2009-10-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application